Vedeler C - Search Results

1

Proteomic-based biomarker discovery with emphasis on cerebrospinal fluid and multiple sclerosis.

Berven FS, Flikka K, Berle M, Vedeler C, Ulvik RJ. Berven FS, et al. Among authors: vedeler c. Curr Pharm Biotechnol. 2006 Jun;7(3):147-58. doi: 10.2174/138920106777549713. Curr Pharm Biotechnol. 2006. PMID: 16789900 Review.

2

Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.

Kroksveen AC, Aasebø E, Vethe H, Van Pesch V, Franciotta D, Teunissen CE, Ulvik RJ, Vedeler C, Myhr KM, Barsnes H, Berven FS. Kroksveen AC, et al. Among authors: vedeler c. J Proteomics. 2013 Jan 14;78:312-25. doi: 10.1016/j.jprot.2012.09.037. Epub 2012 Oct 8. J Proteomics. 2013. PMID: 23059536 Clinical Trial.

3

A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosis.

Rajalahti T, Kroksveen AC, Arneberg R, Berven FS, Vedeler CA, Myhr KM, Kvalheim OM. Rajalahti T, et al. Among authors: vedeler ca. J Proteome Res. 2010 Jul 2;9(7):3608-20. doi: 10.1021/pr100142m. J Proteome Res. 2010. PMID: 20499859

4

Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.

Kroksveen AC, Guldbrandsen A, Vedeler C, Myhr KM, Opsahl JA, Berven FS. Kroksveen AC, et al. Among authors: vedeler c. Acta Neurol Scand Suppl. 2012;(195):90-6. doi: 10.1111/ane.12029. Acta Neurol Scand Suppl. 2012. PMID: 23278663

5

Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome.

Berven FS, Kroksveen AC, Berle M, Rajalahti T, Flikka K, Arneberg R, Myhr KM, Vedeler C, Kvalheim OM, Ulvik RJ. Berven FS, et al. Among authors: vedeler c. Proteomics Clin Appl. 2007 Jul;1(7):699-711. doi: 10.1002/prca.200700126. Proteomics Clin Appl. 2007. PMID: 21136725

6

Pretreatment of mass spectral profiles: application to proteomic data.

Arneberg R, Rajalahti T, Flikka K, Berven FS, Kroksveen AC, Berle M, Myhr KM, Vedeler CA, Ulvik RJ, Kvalheim OM. Arneberg R, et al. Among authors: vedeler ca. Anal Chem. 2007 Sep 15;79(18):7014-26. doi: 10.1021/ac070946s. Epub 2007 Aug 21. Anal Chem. 2007. PMID: 17711295

7

Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis.

Mosleth EF, Vedeler CA, Liland KH, McLeod A, Bringeland GH, Kroondijk L, Berven FS, Lysenko A, Rawlings CJ, Eid KE, Opsahl JA, Gjertsen BT, Myhr KM, Gavasso S. Mosleth EF, et al. Sci Rep. 2021 Feb 18;11(1):4087. doi: 10.1038/s41598-021-82388-w. Sci Rep. 2021. PMID: 33602999 Free PMC article.

8

Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis.

Varhaug KN, Vedeler CA, Myhr KM, Aarseth JH, Tzoulis C, Bindoff LA. Varhaug KN, et al. Among authors: vedeler ca. Mitochondrion. 2017 May;34:32-35. doi: 10.1016/j.mito.2016.12.003. Epub 2016 Dec 23. Mitochondrion. 2017. PMID: 28017684

9

Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.

Vedeler CA, Matre R, Sadallah S, Schifferli J. Vedeler CA, et al. J Neuroimmunol. 1996 Jun;67(1):17-20. doi: 10.1016/0165-5728(96)00035-5. J Neuroimmunol. 1996. PMID: 8707926

10

Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index.

Lunding J, Midgard R, Vedeler CA. Lunding J, et al. Among authors: vedeler ca. Acta Neurol Scand. 2000 Nov;102(5):322-5. doi: 10.1034/j.1600-0404.2000.102005322.x. Acta Neurol Scand. 2000. PMID: 11083510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters